BIONIK LABORATORIES CORP. (BNKL) Financial Statements
BIONIK LABORATORIES CORP. (BNKL) files with the U.S. Securities and Exchange Commission under CIK 0001508381. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2023
- Revenue
- $1.81 million
- Net Income
- -$4.95 million
- Total Assets
- $3.36 million
- Net Cash from Operations
- -$3.39 million
Fiscal year ended Mar 31, 2023. Latest periodic SEC filing: Jun 21, 2023. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for BNKL in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History